4MG-29939-30835
2 vaccinations
6 coded responses
12 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 723 / AR
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- 3J9-26756-87410
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-08-08
Dose 1 — Pfizer-BioNTech
-
2022-08-12
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Constipation — Feeling: Good · Headache · Be unable to do your normal daily activitiesFree text: Severe ConstipationMedDRA releases: 2024-11 · check-in free text available
-
2022-08-14
Health check-in — days 1–6 daily, dose 1, dependentFeeling: Poor · Headache · Be unable to do your normal daily activitiesAdult check-in
- 2022-08-18
-
2022-08-22
Survey response — day 14, dose 1, dependentMedDRA: Cough, Headache, Respiratory tract congestion, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headaches, cough, vomiting, congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Dose 2 — Pfizer-BioNTech
-
2022-09-19
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-20
-
2022-09-23
Survey response — day 7, dose 2, dependentMedDRA: Nasal congestion, Oropharyngeal pain, Productive cough, Rhinorrhoea — Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Sore throat, nasal congestion, coughing with excessive sputum, and runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Survey response — day 14, dose 2, dependentMedDRA: Cough, Headache, Nasal congestion, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fever, cough, runny/stuffy nose, soar throat, and headache.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-30
Report sent to call center — day 14, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-03
-
2022-10-03
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-14
Survey response — day 28, dose 2, dependentMedDRA: Coxsackie viral infection, Hand-foot-and-mouth disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Coxsackie virus (hand, foot, and mouth disease)MedDRA releases: 2024-11 · check-in free text available
-
2022-10-14
Report sent to call center — day 28, dose 2, dependentBe unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-17
Call successfulCompleted over the phone
- 2022-10-21
-
2022-10-30
Survey response — day 42, dose 2, dependentMedDRA: Cough, Respiratory tract congestion — Feeling: FairFree text: Cough, congestion.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-08-08 | Pfizer-BioNTech | No |
| 2 | 2022-09-16 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-09-30 | Successful 2022-10-03 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-14 | Successful 2022-10-17 |
Completed over the phone |
Free text
Release 12 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): Severe Constipation
Release 12 — day 14, dose 1, dependent
Symptoms: Headaches, cough, vomiting, congestion.
Release 12 — day 7, dose 2, dependent
Systemic reaction (other): Sore throat, nasal congestion, coughing with excessive sputum, and runny nose.
Release 12 — day 14, dose 2, dependent
Symptoms: Fever, cough, runny/stuffy nose, soar throat, and headache.
Release 12 — day 28, dose 2, dependent
Symptoms: Coxsackie virus (hand, foot, and mouth disease)
Release 12 — day 42, dose 2, dependent
Symptoms: Cough, congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Coxsackie viral infection | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Constipation | · | · | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Oropharyngeal pain | · | · | ✓ |
| SRO | Productive cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release